Drug Costs Concept

subject area of

• A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline  Academic Article
• A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets  Academic Article
• A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study  Academic Article
• A SECOND LOOK AT PHARMACEUTICAL SPENDING AS DETERMINANTS OF HEALTH OUTCOMES IN CANADA  Academic Article
• A Time-Trend Economic Analysis of Cancer Drug Trials  Academic Article
• A pilot study on cost-related medication nonadherence in Ontario.  Academic Article
• A population-based analysis of incentive payments to primary care physicians for the care of patients with complex disease  Academic Article
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Academic Article
• A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results  Academic Article
• A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.  Conference Paper
• A reappraisal of generic bisphosphonates in osteoporosis  Academic Article
• A review and economic evaluation of bronchodilator delivery methods in hospitalized patients  Academic Article
• An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma  Academic Article
• Andexanet alfa for the treatment of hemorrhage  Academic Article
• Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.  Academic Article
• Antihypertensive treatment – navigating between cost, compliance and complications  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Academic Article
• Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey  Academic Article
• Botulinum Toxin Type A and Acute Drug Costs in Migraine with Triptan Overuse  Academic Article
• COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada  Academic Article
• Calculating the Affordability of Antiretrovirals in St Lucia  Academic Article
• Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma  Academic Article
• Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.  Academic Article
• Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.  Academic Article
• Chemotherapy waste reduction through shelf-life extension.  Academic Article
• Combination Therapy to Prevent Cardiovascular Disease  Academic Article
• Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges  Academic Article
• Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study  Academic Article
• Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model  Academic Article
• Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial  Academic Article
• Cost prediction models for the comparison of two groups  Academic Article
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Academic Article
• Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective  Academic Article
• Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK  Academic Article
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the cure trial  Academic Article
• Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism  Academic Article
• Costs of Remission and Recovery Using Family Therapy for Adolescent Anorexia Nervosa: A Descriptive Report  Academic Article
• Design of Effective Health Decision Support Systems: Towards Automating the Health Administrator's Decision Processes  Academic Article
• Direct and indirect costs incurred by Australian living kidney donors  Academic Article
• Direct and indirect costs of management of long-term warfarin therapy in Canada  Academic Article
• Drug Reimbursement Policies in Canada—Need for Improved Access to Critical Therapies  Academic Article
• Earlier Initialization of Highly Active Antiretroviral Therapy Is Associated With Long-Term Survival and Is Cost-Effective  Academic Article
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme  Academic Article
• Economic analysis of Neoral in de novo renal transplant patients in Canada.  Academic Article
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Academic Article
• Economic issues in glycoprotein IIb/IIIa receptor therapy  Academic Article
• Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care  Academic Article
• Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty  Academic Article
• Erectile dysfunction in spinal cord injury: a cost-utility analysis  Academic Article
• Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.  Academic Article
• Evaluating the impact of reference-based pricing.  Academic Article
• Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report  Conference Paper
• Family Physician attitudes about prescribing using a drug formulary  Academic Article
• General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial  Academic Article
• Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Haemophilia prophylaxis: how can we justify the costs?  Academic Article
• Health economics of gastroesophageal reflux disease.  Academic Article
• Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation  Academic Article
• How do researchers determine the difference to be detected in superiority trials? Results of a survey from a panel of researchers  Academic Article
• Impact of a clinical pharmacist in a multidisciplinary intensive care unit  Academic Article
• Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.  Academic Article
• Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada  Academic Article
• Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial  Academic Article
• Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009  Academic Article
• Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation  Academic Article
• Oral steroids for the resolution of otitis media with effusion (OME) in children (OSTRICH): study protocol for a randomised controlled trial  Academic Article
• Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis  Academic Article
• Patient characteristics and costs of severe sepsis and septic shock in Quebec  Academic Article
• Patients’ Willingness-to-Pay for an Alzheimer’s Disease Medication in Canada  Academic Article
• Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay  Academic Article
• Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus  Academic Article
• Reference-based pricing (RBP) of prescription drugs.  Academic Article
• Resource Use and costs of End-Of-Life/Palliative Care: Ontario Adult Cancer Patients Dying during 2002 and 2003  Academic Article
• Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges  Academic Article
• Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme  Academic Article
• Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data  Academic Article
• Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study  Academic Article
• Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia  Academic Article
• The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial  Academic Article
• The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule: Economic Evaluation  Academic Article
• The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost  Academic Article
• The German method for setting ceiling prices for drugs: in some cases less data are required  Academic Article
• The burden of illness of osteoporosis in Canada  Academic Article
• The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada  Academic Article
• The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada  Academic Article
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Academic Article
• The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.  Academic Article
• Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A  Academic Article
• Valuing Outcomes in Health Care  Academic Article
• What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG Trial  Academic Article